Evrópusambandið - norska - EMA (European Medicines Agency)

biogen idec ltd - daklizumab - multippel sklerose - immunsuppressive - zinbryta er indisert hos voksne pasienter for behandling av tilbakefallende former for multippel sklerose (rms).

Evrópusambandið - norska - EMA (European Medicines Agency)

biogen netherlands b.v. - nusinersen natrium - muskelatrofi, spinal - andre nervesystemet narkotika - spinraza er indisert for behandling av 5q spinal muskelatrofi.

Noregur - norska - Statens legemiddelverk

orifarm as - fampridin - depottablett - 10 mg

Noregur - norska - Statens legemiddelverk

2care4 aps - dimetylfumarat - enterokapsel, hard - 240 mg

Noregur - norska - Statens legemiddelverk

orifarm as - dimetylfumarat - enterokapsel, hard - 240 mg

Noregur - norska - Statens legemiddelverk

orifarm as - dimetylfumarat - enterokapsel, hard - 120 mg

Evrópusambandið - norska - EMA (European Medicines Agency)

biogen netherlands b.v. - diroximel fumarate (biib098) - multippel sklerose, relapsing-remitting - immunsuppressive - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).